Daniel Skovronsky, EVP, CSO and President of LRL and LLY Imm, made one open market purchase of Eli Lilly ($LLY) shares in the past year, totaling $634,405. His most recent buy occurred on August 12, 2025. This ranks him 720th among 4,983 insiders by purchase value, below the average of $1.5 million across 3.3 transactions. Skovronsky reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | A | Common Stock | 15548 | $1044.67 | 235,687.7250 | 945,383,757 | 7.06% | 0.00% |
| Feb. 1, 2026 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | M | Restricted Stock Unit | 12684 | $0.00 | 0.0000 | 945,383,757 | 100.00% | 0.00% |
| Feb. 1, 2026 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | F | Common Stock | 5641 | $1037.15 | 220,139.8630 | 945,383,757 | 2.50% | 0.00% |
| Feb. 1, 2026 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | M | Common Stock | 12684 | $0.00 | 225,781.1120 | 945,383,757 | 5.95% | 0.00% |
| Nov. 10, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CS&PO & Pres. LRL | G | Common Stock | 179 | $0.00 | 213,097.1120 | 945,383,757 | 0.08% | 0.00% |
| Aug. 12, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | P | Common Stock | 1000 | $634.41 | 213,276.1120 | 948,169,999 | 0.47% | 0.00% |
| June 5, 2025 | MYRIAD GENETICS INC | $MYGN | Skovronsky Daniel | Director | A | Common Stock | 49796 | $0.00 | 135,806.0000 | 91,309,064 | 57.90% | 0.05% |
| Feb. 10, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | A | Common Stock | 18772 | $868.88 | 212,276.1120 | 0 | 9.70% | 0.00% |
| Feb. 10, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | A | Restricted Stock Unit | 12684 | $0.00 | 12,684.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | S | Common Stock | 3950 | $862.69 | 194,554.3600 | 0 | 1.99% | 0.00% |
| Feb. 10, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | S | Common Stock | 340 | $863.97 | 194,214.3600 | 0 | 0.17% | 0.00% |
| Feb. 10, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | S | Common Stock | 710 | $865.76 | 193,504.3600 | 0 | 0.37% | 0.00% |
| Feb. 1, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | M | Common Stock | 8989 | $0.00 | 202,508.0000 | 0 | 4.65% | 0.00% |
| Feb. 1, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | F | Common Stock | 4004 | $811.08 | 198,504.3600 | 0 | 1.98% | 0.00% |
| Feb. 1, 2025 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | M | Restricted Stock Unit | 8989 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 11, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | G | Common Stock | 5724 | $0.00 | 193,519.0000 | 0 | 2.87% | 0.00% |
| Sept. 10, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | G | Common Stock | 111 | $0.00 | 199,243.0000 | 0 | 0.06% | 0.00% |
| June 6, 2024 | MYRIAD GENETICS INC | $MYGN | Skovronsky Daniel | Director | A | Common Stock | 15695 | $0.00 | 86,010.0000 | 0 | 22.32% | 0.00% |
| Feb. 12, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | A | Restricted Stock Unit | 8989 | $0.00 | 8,989.0000 | 0 | 9999.99% | 0.00% |
| Feb. 12, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | A | Common Stock | 12910 | $737.26 | 193,738.0000 | 0 | 7.14% | 0.00% |
| Feb. 1, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | M | Restricted Stock Unit | 9941 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 1, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | F | Common Stock | 4434 | $645.61 | 180,828.0000 | 0 | 2.39% | 0.00% |
| Feb. 1, 2024 | ELI LILLY & Co | $LLY | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | M | Common Stock | 9941 | $0.00 | 185,262.0000 | 0 | 5.67% | 0.00% |
| June 1, 2023 | MYRIAD GENETICS INC | $MYGN | Skovronsky Daniel | Director | A | Common Stock | 15151 | $0.00 | 70,315.0000 | 0 | 27.47% | 0.00% |